You must log in to view this page.

Palisade Bio Inc.

NASDAQ: PALI
Share price (8/14/25): $0.81
Market cap (8/14/25): $7.432 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.06

from S-4/A 16 pages Contingent Value Rights Agreement

12/34/56

EX-2.2

from 425 16 pages Contingent Value Rights Agreement

12/34/56

EX-2.2

from 8-K 16 pages Contingent Value Rights Agreement

12/34/56

EX-2.1

from 425 104 pages Agreement and Plan of Merger Among: Seneca Biopharma Inc.; Townsgate Acquisition Sub 1, Inc.; and Leading Biosciences, Inc. Dated as of December 16, 2020

12/34/56

EX-2.1

from 8-K 104 pages Agreement and Plan of Merger Among: Seneca Biopharma Inc.; Townsgate Acquisition Sub 1, Inc.; and Leading Biosciences, Inc. Dated as of December 16, 2020

12/34/56

Palisade Bio Inc. Watch

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

Palisade Bio Inc.